小分子抗生剂的 Ae. 艾吉普提神经Y受体 阻断蚊子咬伤
Laura B Duvall1, Lavoisier Ramos-Espiritu2, Kyrollos E Barsoum1
1Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY 10065, USA.
Cell
|February 9, 2019
概括
研究人员发现了一种新的方法来抑制蚊子对人类的吸引力,使用针对神经类受体7 (NPYLR7) 的药物. 这一发现为控制蚊子传播的疾病提供了一个新的策略.
科学领域:
- 神经科学
- 昆虫学
- 药理学
背景情况:
- 雌性蚊子对人类有很强的吸引力,
- 这种寻找宿主的行为是暂时通过一个未知的机制压制血饭后.
研究的目的:
- 研究与神经Y (NPY) 相关的信号在长期抑制宿主寻找中的作用.
- 识别特定的受体并开发能够调节蚊子疾病控制行为的小分子激动剂.
主要方法:
- 查了49个预测的Aedes aegypti受体,以确定NPY类受体7 (NPYLR7) 作为关键标.
- 对265,211种化合物进行了高通量选,以寻找选择性的NPYLR7激动剂.
- 使用CRISPR-Cas9基因编辑创建NPYLR7无基因突变体进行功能分析.
主要成果:
- 确定NPYLR7是药物调节蚊子寻找宿主行为的唯一目标.
- 隔离了六种高度选择性的NPYLR7激动剂,有效抑制蚊子对人类的吸引力.
- 证明NPYLR7无基因突变体在行为抑制方面受到损害,并且对开发的药物有抗性.
结论:
- 与神经Y相关的信号传递,特别是通过NPYLR7,在抑制蚊子在血液中进食后的吸引力方面发挥着至关重要的作用.
- 开发的NPYLR7选择性激动剂为控制蚊子行为和减少传染病传播提供了有希望的新方法.
- 这项研究强调了针对蚊子神经生物学的潜力,
相关概念视频
Glucagon-like Receptor Agonists
953
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
953
Drug-Receptor Interaction: Agonist
4.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
971
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
971
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
505
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
505
Internal Receptors
74.6K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K
Receptor-mediated Endocytosis
110.8K
Overview
110.8K


